TNDM Q2 2022 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$200M+16.3% YoY

Gross Profit

$102M50.9% margin

Operating Income

-$12M-6.1% margin

Net Income

-$15M-7.5% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+13.8%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$5M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$587M

Stockholders' Equity

$450M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$200M	$172M	+16.3%
Gross Profit	$102M	$92M	+10.3%
Operating Income	-$12M	$5M	-325.3%
Net Income	-$15M	$4M	-475.6%

Geographic Segments

UNITED STATES

$146M73%

Non-US

$55M27%